Cargando…
550. Effectiveness of Remdesivir for Treatment of COVID-19 in the Outpatient Setting
BACKGROUND: Remdesivir (REM) was the first FDA-approved treatment for COVID-19. A clinical trial evaluated the effectiveness of REM for the outpatient treatment of COVID-19, showing an 87% lower risk of hospitalization and death when given within the first 7 days of infectious symptoms in confirmed...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679290/ http://dx.doi.org/10.1093/ofid/ofad500.619 |